Northern Bio’s Leadership & Team
Meet our team of experienced professionals who partner with you to develop next-generation therapeutics.
Experienced Leaders in Preclinical Research
Get to know the experienced scientists and industry leaders who drive our commitment to preclinical excellence.
Shane Woods MS, MBA
Chief Executive Officer
Mark Johnson, MS
Chief Scientific Officer
Chad DesJardin, BBA
Chief Financial Officer
Nancy Gay, MS, MBA
Chief Strategy & Services Officer
Lauren Cohen, JD, BS
Chief Human Resources Officer
Rachel Cooper, DVM, MS, DACLAM
Attending Veterinarian
Michael Pisano, PhD
Site Head, Muskegon Facility
Greg Sweet
Site Head, Norton Shores Facility
Roy French, MSc
Site Head, Portage Facility
Kristin Bell, PhD
Associate Director of Science
Joseph Kiszka, MBA
Business Development Director
Expertise You Can Trust
Our team brings deep experience, advanced training, and a shared commitment to excellence in preclinical research.
- Study Directors
- 7 PhDs and 2 MS-level scientists
- Over 50 years of combined GLP study design experience
- Bioanalytical Scientists
- 3 PhDs and 2 MS degrees
- More than 25 years of experience in GLP laboratories
- Veterinary Team
- ACLAM Diplomate Attending Veterinarian with 7 years of CRO experience
- 3 additional staff veterinarians
- ACVO Diplomate Veterinary Ophthalmologist with 18+ years of preclinical GLP experience
- Quality Assurance Team
- 4 dedicated auditors
- 25+ years of combined GLP auditing experience
- Surgical Team
- 5 specialized surgeons
- Over 60 years of combined targeted delivery expertise
- Technicians
- More than 75 technicians
- 95% hold Bachelor’s or Master’s degrees
Partner With Us
Let’s work together to develop
life-changing treatments.
Join us in the pursuit of better lives through scientific innovation. Explore how Northern Bio can help you achieve your research goals.